We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Abbott Heart Pump Extends Heart Failure Patient Survival Beyond Five Years
Abbott Heart Pump Extends Heart Failure Patient Survival Beyond Five Years
Nearly 60 percent of patients using Abbott’s Heartmate 3 heart pump are reaching the five-year survival mark, according to results of a postmarket study reported at the 2022 European Society of Cardiology Congress in Barcelona, Spain, Aug. 26-29.